NCT03337035View on ClinicalTrials.gov

Probiotics and Oxytocin Nasal Spray on Social Behaviors of Autism Spectrum Disorder (ASD) Children

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

October 2, 2019

Study Completion Date

October 2, 2019

Conditions
Autism Spectrum Disorder
Interventions
DRUG

intranasal oxytocin

4-24 IU per day, dosage gradually increases

DIETARY_SUPPLEMENT

oral probiotics

200 million cfu per day

DIETARY_SUPPLEMENT

oral placebo

2 pills per day

Trial Locations (1)

02129

Massachusetts General Hospital, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03337035 - Probiotics and Oxytocin Nasal Spray on Social Behaviors of Autism Spectrum Disorder (ASD) Children | Biotech Hunter | Biotech Hunter